XML 14 R4.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
REVENUES        
Government contract revenue $ 0 $ 131,966 $ 0 $ 263,932
OPERATING EXPENSES        
Professional fees 1,003,870 649,460 1,847,899 1,232,929
Payroll and related expenses 1,112,955 805,608 2,142,641 1,822,350
General and administrative 1,548,484 685,702 2,582,505 1,315,895
Total operating expenses 3,665,309 2,140,770 6,573,045 4,371,174
OPERATING LOSS (3,665,309) (2,008,804) (6,573,045) (4,107,242)
OTHER EXPENSE        
Loss on dissolution of subsidiary 142,121 0 142,121 0
NET LOSS (3,807,430) (2,008,804) (6,715,166) (4,107,242)
LOSS ATTRIBUTABLE TO NONCONTROLLING INTERESTS 0 (825) 0 (1,960)
NET LOSS ATTRIBUTABLE TO AETHLON MEDICAL, INC. $ (3,807,430) $ (2,007,979) $ (6,715,166) $ (4,105,282)
BASIC LOSS PER SHARE $ (0.18) $ (0.13) $ (0.37) $ (0.29)
DILUTED LOSS PER SHARE $ (0.18) $ (0.13) $ (0.37) $ (0.29)
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING – BASIC 20,744,999 15,386,486 18,130,177 14,114,639
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING – DILUTED 20,744,999 15,386,486 18,130,177 14,114,639